Bukwang Pharm took over the Danish bio-venture ‘Contera’
Bukwang Pharm (executive director Sang-hoon Kim) announced on the 25ththat the company acquired the 100% shares of ‘Contera Pharma’, a bio-venture specializing in CNS and located in Copenhagen, Denmark, and completed the buyout procedure on the 24th.
A person concerned in Bukwang Pharm stated “B...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
